Essential thrombocytosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
==Prognosis==
==Prognosis==
Essential thrombocytosis is a gradually progressive disorder with long asymptomatic periods punctuated by thrombotic or hemorrhagic events. Under medial supervision, the life expectancy is usually normal.
Though Essential thrombocytosis is a gradually progressive disorder, most of the patients remain asymptomatic for most of their life, usually being diagnosed in their 50's or 60's. Those with significantly elevated numbers (>600-1000 platelets/μL of blood) complications are from bleeding and blood clots in the vasculature. Under medial supervision, the life expectancy is usually normal. Rarely the disease may progress to acute leukemia.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 17:01, 2 November 2015

Essential thrombocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology and Demographics

Risk Factors

Screening

Causes

Differentiating Essential thrombocytosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Essential thrombocytosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Essential thrombocytosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Essential thrombocytosis natural history, complications and prognosis

CDC on Essential thrombocytosis natural history, complications and prognosis

Essential thrombocytosis natural history, complications and prognosis in the news

Blogs on Essential thrombocytosis natural history, complications and prognosis

Directions to Hospitals Treating Essential thrombocytosis

Risk calculators and risk factors for Essential thrombocytosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Prognosis

Though Essential thrombocytosis is a gradually progressive disorder, most of the patients remain asymptomatic for most of their life, usually being diagnosed in their 50's or 60's. Those with significantly elevated numbers (>600-1000 platelets/μL of blood) complications are from bleeding and blood clots in the vasculature. Under medial supervision, the life expectancy is usually normal. Rarely the disease may progress to acute leukemia.

References


Template:WikiDoc Sources